$ASNS X4 Pharmaceuticals, Inc Insider Trading
Get free email notifications about insider trading in X4 Pharmaceuticals, Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in X4 Pharmaceuticals, Inc. Insider overview, share value development, latest insider transactions and email notifications about new events in X4 Pharmaceuticals, Inc for free.
CIK Number: 0001501697
IRS Number: 273181608
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ASNS
Company Address: 61 NORTH BEACON STREET 4TH FLOOR BOSTON 02134
Phone number: 781-819-5704
Former name: Arsanis, Inc., date of change: 2010-09-20
X4 Pharmaceuticals, Inc Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | ASNS | X4 Pharmaceuticals ... | Bridger Gary | Director | Option Exercise | A | 9.50 | 6,000 | 57,000 | 6,000 | |
Jun 02 2021 | ASNS | X4 Pharmaceuticals ... | Aliski William | Director | Option Exercise | A | 9.50 | 6,000 | 57,000 | 6,000 | |
May 04 2021 | ASNS | X4 Pharmaceuticals ... | Ragan Paula | President and CEO | Sell | S | 8.33 | 2,400 | 19,992 | 412,752 | 415.2 K to 412.8 K (-0.58 %) |
Apr 07 2021 | ASNS | X4 Pharmaceuticals ... | Ragan Paula | President and CEO | Sell | S | 9.17 | 2,400 | 22,008 | 415,152 | 417.6 K to 415.2 K (-0.57 %) |
Feb 03 2021 | ASNS | X4 Pharmaceuticals ... | Ragan Paula | President and CEO | Sell | S | 7.88 | 2,400 | 18,912 | 275,323 | 277.7 K to 275.3 K (-0.86 %) |
Jan 06 2021 | ASNS | X4 Pharmaceuticals ... | Ragan Paula | President and CEO | Sell | S | 7.00 | 2,400 | 16,800 | 277,723 | 280.1 K to 277.7 K (-0.86 %) |
Jan 06 2021 | ASNS | X4 Pharmaceuticals ... | Cadavid Diego | Chief Medical Offic ... | Option Exercise | A | 6.43 | 121,500 | 781,245 | 121,500 | |
Dec 28 2020 | ASNS | X4 Pharmaceuticals ... | Ragan Paula | President and CEO | Sell | S | 7.00 | 4,800 | 33,600 | 280,123 | 284.9 K to 280.1 K (-1.68 %) |
Dec 01 2020 | ASNS | X4 Pharmaceuticals ... | Taveras Arthur | Chief Scientific Of ... | Option Exercise | A | 6.60 | 121,150 | 799,590 | 121,150 | |
Oct 21 2020 | ASNS | X4 Pharmaceuticals ... | Stewart Murray | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
Oct 06 2020 | ASNS | X4 Pharmaceuticals ... | Ragan Paula | President and CEO | Sell | S | 7.00 | 1,797 | 12,579 | 284,923 | 286.7 K to 284.9 K (-0.63 %) |
Oct 06 2020 | ASNS | X4 Pharmaceuticals ... | Lawton Alison Frances | Director | Option Exercise | A | 7.33 | 6,854 | 50,240 | 6,854 | |
Sep 22 2020 | ASNS | X4 Pharmaceuticals ... | Mostafa Adam S. | Chief Financial Off ... | Sell | S | 7.08 | 10,834 | 76,705 | 29,589 | 40.4 K to 29.6 K (-26.80 %) |
Sep 10 2020 | ASNS | X4 Pharmaceuticals ... | Skerlj Renato | Chief Scientific Of ... | Sell | S | 8.05 | 5,834 | 46,964 | 42,076 | 47.9 K to 42.1 K (-12.18 %) |
Sep 10 2020 | ASNS | X4 Pharmaceuticals ... | Ragan Paula | President and CEO | Sell | S | 8.04 | 8,840 | 71,074 | 287,323 | 296.2 K to 287.3 K (-2.98 %) |